Researchers developed an AI model that accurately distinguishes between multiple dementia types using extensive, heterogeneous brain imaging data.
Key Details
- 1The model was trained and tested on 308,000 3D brain images from 17,000 patients collected over two decades.
- 2It detects vascular dementia, Alzheimer's, Lewy body dementia, Parkinson's, and mild cognitive impairment, with AUC >0.84 for these conditions.
- 3The dataset included multiple modalities (T1 MRI, T2 MRI, CT, PET), reflecting real-world clinical complexity and variation.
- 4The neural network is structured to handle varying numbers and types of images per patient (1–14), mitigating confounding variables like scanning site and age.
- 5Testing across multiple hospital sites demonstrated the model’s robustness to real-world heterogeneity.
- 6Future directions include larger datasets and development of explainable AI for neuroimaging disease detection.
Why It Matters
This study addresses a major barrier for clinical translation of imaging AI—performance on real-world, heterogeneous datasets—demonstrating a feasible path for deploying robust differential diagnostic tools across healthcare settings.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.